Xylem (NYSE:XYL) Research Coverage Started at UBS Group

UBS Group started coverage on shares of Xylem (NYSE:XYL) in a report published on Tuesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $165.00 target price on the industrial products company’s stock.

XYL has been the topic of several other research reports. TD Cowen raised their price target on Xylem from $135.00 to $138.00 and gave the company a buy rating in a research note on Thursday, June 6th. Stifel Nicolaus boosted their price target on shares of Xylem from $170.00 to $172.00 and gave the company a buy rating in a report on Wednesday, July 31st. Robert W. Baird increased their price objective on shares of Xylem from $155.00 to $170.00 and gave the company an outperform rating in a research note on Wednesday, July 31st. Oppenheimer boosted their price objective on shares of Xylem from $147.00 to $152.00 and gave the stock an outperform rating in a research note on Friday, May 31st. Finally, Mizuho increased their target price on Xylem from $110.00 to $135.00 and gave the company a neutral rating in a research report on Friday, May 3rd. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus price target of $147.54.

Xylem Price Performance

Xylem stock opened at $133.19 on Tuesday. The stock has a market cap of $32.35 billion, a price-to-earnings ratio of 47.40, a price-to-earnings-growth ratio of 2.32 and a beta of 1.04. The firm has a 50-day moving average of $135.61 and a two-hundred day moving average of $132.12. Xylem has a 1 year low of $87.59 and a 1 year high of $146.08. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.85 and a quick ratio of 1.33.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.14 billion. Xylem had a return on equity of 9.48% and a net margin of 9.11%. Xylem’s quarterly revenue was up 26.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.98 earnings per share. On average, research analysts forecast that Xylem will post 4.25 earnings per share for the current year.

Insider Buying and Selling at Xylem

In other news, SVP Rodney Aulick sold 21,800 shares of Xylem stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares in the company, valued at $10,604,655.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares in the company, valued at $490,195.68. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the transaction, the senior vice president now owns 76,287 shares in the company, valued at approximately $10,604,655.87. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

Institutional Trading of Xylem

Large investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC lifted its position in Xylem by 68.8% during the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after purchasing an additional 77 shares during the period. Whittier Trust Co. of Nevada Inc. raised its stake in shares of Xylem by 3.5% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 2,317 shares of the industrial products company’s stock valued at $299,000 after buying an additional 79 shares during the last quarter. Addison Advisors LLC lifted its holdings in shares of Xylem by 5.8% in the 2nd quarter. Addison Advisors LLC now owns 1,486 shares of the industrial products company’s stock valued at $202,000 after buying an additional 82 shares during the period. Waycross Investment Management Co boosted its stake in shares of Xylem by 1.8% in the second quarter. Waycross Investment Management Co now owns 4,895 shares of the industrial products company’s stock worth $664,000 after buying an additional 87 shares during the last quarter. Finally, Bleakley Financial Group LLC grew its holdings in Xylem by 2.3% during the first quarter. Bleakley Financial Group LLC now owns 4,042 shares of the industrial products company’s stock worth $522,000 after acquiring an additional 90 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.